Safety of switching from brand-name to generic levetiracetam in patients with epilepsy

PURPOSE: The approach to the use of generic antiepileptic drugs has recently evolved from major concern to general acceptance, but the evidence related specifically to the safety of switching from brand-name to generic levetiracetam (LEV) is scarce. The aim of the study was to assess the risk of inc...

Descripción completa

Detalles Bibliográficos
Autores principales: Bosak, Magdalena, Słowik, Agnieszka, Turaj, Wojciech
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546726/
https://www.ncbi.nlm.nih.gov/pubmed/28814836
http://dx.doi.org/10.2147/DDDT.S138270

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546726/
https://www.ncbi.nlm.nih.gov/pubmed/28814836
http://dx.doi.org/10.2147/DDDT.S138270

Ejemplares similares